Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial

BACKGROUND: The evidence for choices between antipsychotics for children and adolescents with schizophrenia and other psychotic disorders is limited. The main objective of the Tolerability and Efficacy of Antipsychotics (TEA) trial is to compare the benefits and harms of quetiapine versus aripiprazo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagsberg, Anne Katrine, Jeppesen, Pia, Klauber, Dea Gowers, Jensen, Karsten Gjessing, Rudå, Ditte, Stentebjerg-Olesen, Marie, Jantzen, Peter, Rasmussen, Simone, Saldeen, Eva Ann-Sofie, Lauritsen, Maj-Britt Glenn, Bilenberg, Niels, Stenstrøm, Anne Dorte, Pedersen, Jesper, Nyvang, Louise, Madsen, Sarah, Lauritsen, Marlene B, Vernal, Ditte Lammers, Thomsen, Per Hove, Paludan, Jakob, Werge, Thomas M, Winge, Kristian, Juul, Klaus, Gluud, Christian, Skoog, Maria, Wetterslev, Jørn, Jepsen, Jens Richardt M, Correll, Christoph U, Fink-Jensen, Anders, Fagerlund, Birgitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227115/
https://www.ncbi.nlm.nih.gov/pubmed/25015535
http://dx.doi.org/10.1186/1471-244X-14-199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227115/
https://www.ncbi.nlm.nih.gov/pubmed/25015535
http://dx.doi.org/10.1186/1471-244X-14-199

Ejemplares similares